Richard T Coughlin

Title: Richard T Coughlin: Innovator in Lantibiotic Purification

Introduction

Richard T Coughlin is a notable inventor based in Falmouth, ME (US). He has made significant contributions to the field of antibiotic purification, particularly through his innovative methods for isolating lantibiotics. His work has implications for the pharmaceutical industry, especially in the development of effective antibiotics.

Latest Patents

Coughlin holds a patent for a method of purifying lantibiotics. This patent, which is particularly focused on the antibiotic nisin, outlines a process for extracting the antibiotic from a crude or partially purified solution. The method involves creating an incubation mixture that includes the solution containing the lantibiotic and a proteolytic enzyme, which is then incubated under conditions that optimize selective proteolytic activity. This innovative approach enhances the purification process for other members of the lantibiotic genus as well.

Career Highlights

Throughout his career, Richard T Coughlin has worked with several companies, including Immucell Corporation and Sequela, Inc. His experience in these organizations has allowed him to apply his expertise in antibiotic research and development, contributing to advancements in the field.

Collaborations

Coughlin has collaborated with notable professionals in his field, including Joseph H Crabb and Stephen L Carrithers. These collaborations have further enriched his research and development efforts, leading to innovative solutions in antibiotic purification.

Conclusion

Richard T Coughlin's contributions to the field of antibiotic purification, particularly through his patented methods, highlight his role as an innovator in the pharmaceutical industry. His work continues to influence the development of effective antibiotics, showcasing the importance of innovation in healthcare.